Response to the letter to the editor: 'Olezarsen, a liver-directed APOC3 ASO therapy for hypertriglyceridemia'

Expert Opin Pharmacother. 2025 Jan;26(1):111-112. doi: 10.1080/14656566.2024.2437524. Epub 2024 Dec 8.
No abstract available

Keywords: APOC3 antisense; Olezarsen; thrombocytopenia; volanesorsen.